|
ÇÏÀÌÅ×Å© ºÐ¾ßÀÇ ÄÁ¼³Å×ÀÌ¼Ç ¹× ½ÃÀåÁ¶»ç¸¦ Àü¹®À¸·Î Çϰí ÀÖ´Â ¹Ì±¹ÀÇ Á¶»çȸ»ç Frost & Sullivan (º»»ç : ÅØ»ç½ºÁÖ) ¿¡¼´Â ¹Ì±¹ÀÇ Ãµ½Ä/¸¸¼ºÆó¼â¼ºÆóÁúȯ (COPD) ½ÃÀå¿¡ ´ëÇÑ Á¶»ç ºÐ¼® º¸°í¼ "U.S. Asthma/COPD Market"À» ¹ßÇàÇß½À´Ï´Ù.
¹Ì±¹ õ½Ä/COPD ½ÃÀåÀÇ 2003¡2013³â µ¿Çâ ¹× È¯ÀÚ¿¹Ãø, ¼¼ºÐ½ÃÀ庰 ¼öÀÍ¿¹Ãø, ½ÃÀåÁ¡À¯À² ºÐ¼® µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.
Á¦2Àå ½ÃÀå ¼·Ð
- °³¿ä
- º´ÀÇ °³¿ä
- õ½Ä
- ¸¸¼ºÆó¼â¼ºÆóÁúȯ (COPD)
- Ä¡·á¹æ¹ý
- ½ÃÀå°³¿ä
- ½ÃÀå±â¼úÆò°¡
- ¾÷°èÀÇ °úÁ¦ ¹× Àü·«Àû Á¦¾ð
- ½ÃÀåÃËÁø¿äÀÎ
- ½ÃÀåÀúÇØ¿äÀÎ
Á¦3Àå ½ÃÀåºÐ¼®
- °æÇպм®
- ȯÀÚ¿¹Ãø
- ȯÀÚ¿¹Ãø : õ½Ä
- ȯÀÚ¿¹Ãø : COPD
- ÃÑȯÀÚ¼ö ¿¹Ãø
- ¼öÀÍ¿¹Ãø
- ½ÃÀå ¼öÀÍ¿¹Ãø
- ½ÃÀåÁ¡À¯À² ºÐ¼®
Á¦4Àå ±â°üÁöÈ®ÀåÁ¦ (Bronchodilators) ½ÃÀå
- ¼·Ð
- ¼·Ð
- ½ÃÀå±â¼úÆò°¡
- ¼öÀÍ¿¹Ãø
- ½ÃÀåÁ¡À¯À² ºÐ¼®
- SABA (Short-Acting Beta-2 Agonists) ½ÃÀå
- ¼·Ð
- ¼öÀÍ¿¹Ãø
- Á¦Ç° ºÐ¼®
- ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®
- LABA (Long-Acting Beta-2 Agonists) ½ÃÀå
- ¼·Ð
- ¼öÀÍ¿¹Ãø
- Á¦Ç° ºÐ¼®
- ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®
- Ç×Äݸ°Á¦ (Anticholinergics) ½ÃÀå
- ¼·Ð
- ¼öÀÍ¿¹Ãø
- Á¦Ç° ºÐ¼®
- ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®
- º´¿ë ±â°üÁöÈ®ÀåÁ¦
- ¼·Ð
- ¼öÀÍ¿¹Ãø
- Á¦Ç° ºÐ¼®
- ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®
Á¦5Àå Ç׿°ÁõÁ¦ (Anti-Inflammatory) ½ÃÀå
- ¼·Ð
- ¼·Ð
- ½ÃÀå±â¼úÆò°¡
- ¼öÀÍ¿¹Ãø
- ½ÃÀåÁ¡À¯À² ºÐ¼®
- ÈíÀÔ¿ë ÄÚÆ¼ÄÚ½ºÅ×·ÎÀ̵å (Inhaled Corticosteroids) ½ÃÀå
- ¼·Ð
- ¼öÀÍ¿¹Ãø
- Á¦Ç° ºÐ¼®
- ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®
- ÈÇиŰ³Ã¼ ºÐºñ ¾ïÁ¦Á¦ (Mediator-Release Inhibitor) ½ÃÀå
- ¼·Ð
- ¼öÀÍ¿¹Ãø
- Á¦Ç° ºÐ¼®
- ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®
- Ç×·ùÄÚÆ®¸®¿£ (Anti-Leukotriene) ½ÃÀå
- ¼·Ð
- ¼öÀÍ¿¹Ãø
- Á¦Ç° ºÐ¼®
- ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®
- ¸ð³ëŬ·Î³ÎÇ×ü (Monoclonal Antibody) ½ÃÀå
- ¼·Ð
- ¼öÀÍ¿¹Ãø
- Á¦Ç° ºÐ¼®
- ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®
- ±âŸ ½ÅÈï Ç׿°ÁõÁ¦
Á¦6Àå º´¿ë¿ä¹ý ½ÃÀå
- º´¿ë¿ä¹ý
- ¼·Ð
- ½ÃÀå±â¼úÆò°¡
- ¼öÀÍ¿¹Ãø
- Á¦Ç° ºÐ¼®
- ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®
ksm
|